Table: Medrx - 9-MTH group results

Medrx

10/11/2023 06:01

Nov 10 (Reuters)- 
             Medrx.Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            29 mln               9 mln            27 mln     
                (+208.8 pct)         (+14.0 pct)       (+46.8 pct)  
  Operating     loss 670 mln        loss 621 mln        loss 1.05   
  Recurring     loss 668 mln        loss 636 mln        loss 1.00   
  Net           loss 671 mln        loss 635 mln        loss 1.01   
  EPS          loss 20.00 yen      loss 25.82 yen    loss 26.23 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Medrx.Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T